23 results
10-Q
2024 Q1
NAMS
NewAmsterdam Pharma Company NV
8 May 24
Quarterly report
4:30pm
suppliers for those materials that are currently or in the future purchased from a sole or single source supplier;
operations of our third-party … manufacturers or suppliers could be disrupted by conditions unrelated to our business or operations, including the bankruptcy of the manufacturer or supplier
10-K
2023 FY
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
or supplier of services reimbursable by Medicare or a state healthcare program.
The federal Health Insurance Portability and Accountability Act … from a sole or single source supplier;
operations of our third-party manufacturers or suppliers could be disrupted by conditions unrelated to our
8-K
EX-1.1
NAMS
NewAmsterdam Pharma Company NV
15 Feb 24
NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
4:18pm
supplier, manufacturer, customer or contractor of the Company, exists or, to the knowledge of the Company, is threatened or imminent.
(v) Intellectual
F-3
EX-1.2
NAMS
NewAmsterdam Pharma Company NV
7 Dec 23
Shelf registration (foreign)
4:16pm
with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor
424B3
NAMS
NewAmsterdam Pharma Company NV
15 Aug 23
Prospectus supplement
4:52pm
. We also currently rely on a single supplier for our active ingredient and finished product for obicetrapib. While we believe that alternative sources … purchased from a sole or single source supplier;
operations of our third-party manufacturers or suppliers could be disrupted by conditions unrelated to our
POS AM
k8d64ubd2u8
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
6-K
EX-99.2
391 mtxzed3gye
7 Aug 23
Research and development expenses
7:24am
424B3
gcnvr5loxtn 7o64
9 Jun 23
Prospectus supplement
9:43pm
6-K
EX-1.1
1bssq6t4sy1
9 Jun 23
Current report (foreign)
9:39pm
424B3
9y0 jpqubx
8 Jun 23
Prospectus supplement
5:01pm
424B3
d00eij3
6 Jun 23
Prospectus supplement
4:20pm
424B3
qtqst zlm
25 Apr 23
Prospectus supplement
8:14am
POS AM
mtholz4ygbhv7
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
drlt35ryk991sp40y
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
EX-2.1
x62ti7syb00oumoyl ub
23 Nov 22
Current report (foreign)
4:36pm
424B3
kmdps78b3gcekniop1cj
18 Oct 22
Prospectus supplement
4:41pm
F-4/A
1kk6yvh
13 Oct 22
Registration of securities (foreign) (amended)
5:18pm
F-4/A
2dcxxfk9xaq
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
hyne6vtsnaobcvdphjw7
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm